At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Trial of Hypofractionated Radiation Therapy for Prostate Cancer With High Risk Features After Radical Prostatectomy
In Brief
A Phase 2 clinical trial evaluating Androgen Suppression, Hypofractionated Radiation Therapy, and 2 other interventions for Prostate Adenocarcinoma and 5 related conditions. Completed, enrolled 53 participants across 2 sites.
Detailed Summary
This phase II trial studies how well hypofractionated radiation therapy works in treating participants with prostate cancer high-risk features following radical prostatectomy. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Study Details
Timeline
Interventions
Given androgen suppression therapy
Undergo hypofractionated radiation therapy
Ancillary studies
Ancillary studies